Status:

UNKNOWN

Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions

Lead Sponsor:

R&D Cardiologie

Collaborating Sponsors:

Biotronik SE & Co. KG

Conditions:

Coronary Artery Disease

Coronary Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

Percutaneous recanalization of total coronary occlusions (TCO) was historically hampered by high rates of restenosis and reocclusion. In the PRISON II and III trial we showed landmark reduction in res...

Detailed Description

A total of 330 patients are randomized to either hybrid sirolimus-eluting stent or everolimus-eluting stent after successful recanalization of TCO. Clinical follow-up at 1, 6, 12 months, 2, 3, 4, 5 ye...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • the estimated duration of the occlusion is at least 4 weeks.
  • signs of ischemia related to the occluded coronary artery.
  • successful recanalization of the occluded artery is achieved.
  • reference diameter is \> 2.5 mm.
  • written informed consent obtained.
  • EXCLUSION CRITERIA:
  • primary or rescue PCI for acute myocardial infarction
  • the lesion could not be crossed.
  • lesions with complex anatomy making successful stent deployment unlikely.
  • the guide wire is not in the true lumen distal to the occlusion.
  • Sirolimus or zotarolimus allergy
  • venous or arterial bypass grafts
  • pregnant or nursing women.
  • participation in an other trial.
  • factors making long-term follow-up difficult or unlikely.
  • life expectancy \< 1 year.
  • contraindications for ASA or Clopidogrel or heparin.
  • use of coumadins that could not be stopped before the procedure.

Exclusion

    Key Trial Info

    Start Date :

    February 1 2012

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2020

    Estimated Enrollment :

    330 Patients enrolled

    Trial Details

    Trial ID

    NCT01516723

    Start Date

    February 1 2012

    End Date

    May 1 2020

    Last Update

    March 28 2017

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    AZ Middelheim

    Antwerp, Antwerpen, Belgium, 2020

    2

    AMC

    Amsterdam, Amsterdam, Netherlands, 1105AZ

    3

    Catharina Ziekenhuis

    Eindhoven, Eindhoven, Netherlands, 5602ZA

    4

    St Antonius Hospital

    Nieuwegein, Netherlands, 3435CM